EBS

Quote

Short

News

Articles

Message Board

Emergent BioSolutions Inc. (NYSE : EBS ) News

News Releases

EBS News Releases

June 29, 2026 09:13:13 am

GlobeNewswire

Emergent BioSolutions Secures Contract Modification Valued at Approximately $52.7 Million for ACAM2000® (Smallpox and Mpox (Vaccinia) Vaccine, Live) from the U.S. Government

June 08, 2026 05:27:36 pm

SeekingAlpha

Emergent BioSolutions: Down 40%+ From Recent Highs And Likely More To Come

June 08, 2026 04:08:31 pm

SeekingAlpha

Emergent BioSolutions Inc. (EBS) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Prepared Remarks Transcript

June 01, 2026 10:20:19 am

SeekingAlpha

These 10 small-cap U.S. healthcare giants rank among the market's most attractively valued stocks

May 28, 2026 04:01:00 pm

GlobeNewswire

Emergent BioSolutions Receives $64.5 Million Contract Modification for BAT® [Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G) - (Equine)] to Support U.S. Biodefense Strategy

May 18, 2026 08:59:00 am

GlobeNewswire

Emergent BioSolutions Receives Saudi Food and Drug Authority Approval for ACAM2000® [Smallpox and Mpox (Vaccinia) Vaccine, Live]

May 01, 2026 12:26:06 pm

Motley Fool

Emergent (EBS) Q1 2026 Earnings Transcript

May 01, 2026 11:12:26 am

SeekingAlpha

Emergent outlines $170M-$185M Q2 revenue outlook while maintaining $720M-$760M 2026 revenue guidance

May 01, 2026 11:11:33 am

SeekingAlpha

Emergent BioSolutions Inc. (EBS) Q1 2026 Earnings Call Transcript

April 30, 2026 04:32:48 pm

SeekingAlpha

Emergent Biosolutions Non-GAAP EPS of $0.21 beats by $0.46, revenue of $156.1M beats by $11.1M

	Next 10

Subscribe to Our Newsletter

Download The Market Wire News App

Link Market Wire News to Your X Account